ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE(receptor for advanced glycation end products) and TLR4 (toll-like receptor 4). ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI).
Molecular Weight:
394.63
Purity:
98.63%
CAS Number:
[1638200-22-2]
Formula:
C11H9BrClN3O4S
Target:
TLR
T39115
* VAT and and shipping costs not included. Errors and price changes excepted